These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7541138)

  • 1. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.
    Thomson SA; Khanna R; Gardner J; Burrows SR; Coupar B; Moss DJ; Suhrbier A
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5845-9. PubMed ID: 7541138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
    J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope.
    Zajac P; Oertli D; Spagnoli GC; Noppen C; Schaefer C; Heberer M; Marti WR
    Int J Cancer; 1997 May; 71(3):491-6. PubMed ID: 9139889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.
    Thomson SA; Elliott SL; Sherritt MA; Sproat KW; Coupar BE; Scalzo AA; Forbes CA; Ladhams AM; Mo XY; Tripp RA; Doherty PC; Moss DJ; Suhrbier A
    J Immunol; 1996 Jul; 157(2):822-6. PubMed ID: 8752934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG
    J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
    Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
    Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
    J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
    Nixon DF; Townsend AR; Elvin JG; Rizza CR; Gallwey J; McMichael AJ
    Nature; 1988 Dec; 336(6198):484-7. PubMed ID: 2461519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
    Cardinaud S; Bouziat R; Rohrlich PS; Tourdot S; Weiss L; Langlade-Demoyen P; Burgevin A; Fiorentino S; van Endert P; Lemonnier FA
    AIDS; 2009 Sep; 23(15):1945-54. PubMed ID: 19644347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
    Khanna R; Jacob CA; Burrows SR; Kurilla MG; Kieff E; Misko IS; Sculley TB; Moss DJ
    Immunology; 1991 Nov; 74(3):504-10. PubMed ID: 1722774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Lee SP; Morgan S; Skinner J; Thomas WA; Jones SR; Sutton J; Khanna R; Whittle HC; Rickinson AB
    Eur J Immunol; 1995 Jan; 25(1):102-10. PubMed ID: 7531142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
    Lee SP; Thomas WA; Blake NW; Rickinson AB
    Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
    Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
    Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an overlapping CD8+ and CD4+ T-cell epitope on rubella capsid protein.
    Ou D; Mitchell LA; Décarie D; Gillam S; Tingle AJ
    Virology; 1997 Sep; 235(2):286-92. PubMed ID: 9281508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.